BIOMARKER:

RB1 mutation

Entrez ID:

Related biomarkers:

‹

›

RB1 mutation RB1 mutation	Urothelial Cancer Urothelial Cancer	pembrolizumab Sensitive: C3 – Early Trials
RB1 mutation RB1 mutation	Bladder Cancer Bladder Cancer	pembrolizumab Sensitive: C3 – Early Trials
RB1 mutation RB1 mutation	Small Cell Lung Cancer Small Cell Lung Cancer	nivolumab Resistant: C3 – Early Trials
RB1 mutation RB1 mutation	Prostate Cancer Prostate Cancer	AST-2970 Resistant: C3 – Early Trials
RB1 mutation RB1 mutation	Prostate Cancer Prostate Cancer	docetaxel Resistant: C3 – Early Trials
RB1 mutation RB1 mutation	Triple Negative Breast Cancer Triple Negative Breast Cancer	carboplatin + docetaxel Sensitive: C3 – Early Trials
RB1 mutation RB1 mutation	Ovarian Cancer Ovarian Cancer	carboplatin + paclitaxel Resistant: C3 – Early Trials
RB1 mutation RB1 mutation	Prostate Cancer Prostate Cancer	cyclophosphamide oral + dexamethasone Sensitive: C4 – Case Studies
RB1 mutation RB1 mutation	Meningioma Meningioma	palbociclib Sensitive: D – Preclinical
RB1 mutation RB1 mutation	Ovarian Cancer Ovarian Cancer	abemaciclib Resistant: D – Preclinical
RB1 mutation RB1 mutation	Small Cell Lung Cancer Small Cell Lung Cancer	nivolumab + ipilimumab Resistant: D – Preclinical